Risk Communication Strategies for Medical Countermeasure Distribution

Focus Groups as Used by the Food and Drug Administration

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0497 can be found here:

Documents and Forms

Document Name Document Type
Risk Communication-Medical Countermeasure Distribution-mod guide.doc Other-moderator's guide
risk comm write up.doc risk comm write up IC Document
OMB justification memo final.doc OMB justification memo final IC Document
1-16 DoxycyclineSummaryFactSheet_16Jan09_tracked.doc fact sheet IC Document
AnthraxEUAtrifold 4April05.pdf trifold fact sheet IC Document
ATTACHMENT 2 Doxy Recipient Fact sheet.doc recipient fact sheet multi page IC Document
terms of clearance.doc terms of clearance IC Document

Information Collection (IC) Details

IC Title:	Risk Communication Strategies for Medical Countermeasure Distribution	Agency IC Tracking Number:

IC Status: New

Obligation to Respond: Voluntary

CFR Citation:

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-moderator's guide			Risk Communication-Medical Countermeasure Distribution-mod guide.doc		No	No	Paper Only

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 36	Number of Respondents for Small Entity: 0

Affected Public: Individuals or Households

Percentage of Respondents Reporting Electronically: 0 %

	Approved	Program Change Due to New Statute	Program Change Due to Agency Discretion	Change Due to Adjustment in Agency Estimate	Change Due to Potential Violation of the PRA	Previously Approved
Annual Number of Responses for this IC	36	0	0	0	0	0
Annual IC Time Burden (Hours)	58	0	0	0	0	0
Annual IC Cost Burden (Dollars)	0	0	0	0	0	0

Documents for IC

Title	Document	Date Uploaded
risk comm write up	risk comm write up.doc	12/02/2009
OMB justification memo final	OMB justification memo final.doc	12/02/2009
fact sheet	1-16 DoxycyclineSummaryFactSheet_16Jan09_tracked.doc	02/10/2010
trifold fact sheet	AnthraxEUAtrifold 4April05.pdf	02/10/2010
recipient fact sheet multi page	ATTACHMENT 2 Doxy Recipient Fact sheet.doc	02/10/2010
terms of clearance	terms of clearance.doc	02/10/2010

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.